货号:A510332
同义名:
N-[4-[3,5-Bis(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-3-fluoro-4-pyridinecarboxamide
Pyr6 is a selective inhibitor of TRPC3 with IC50 of 0.49 μM (Ca2+ influx inhibition in thapsigargin depleted native RBL-2H3 cells).
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Pyr6 acts as a selective TRPC3 inhibitor, exhibiting an IC50 of 0.49 μM for inhibiting Ca2+ influx in thapsigargin-depleted native RBL-2H3 cells. The IC50 value is 0.49 μM[1]. The TRPC3 inhibitor Pyr6 is a specific suppressor of SOCE (Yonetoku et al., 2008; Sweeney et al., 2009). It demonstrates a 37-fold (1.58 OM) increase in efficacy for RBL SOCE compared to TRPC3 ROCE, with an IC50 similar to that of Pyr2 and Pyr3. At 3 uM concentration, Pyr6 reduces TRPC3 currents to only 52%. Moreover, consistent with the inhibition of Orai channel function, Pyr2, Pyr3, or Pyr6 significantly impede typical Orai downstream signaling pathways in RBL mast cells (NFAT activation and degranulation) triggered by passive store depletion. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.39mL 0.48mL 0.24mL |
11.95mL 2.39mL 1.20mL |
23.91mL 4.78mL 2.39mL |
CAS号 | 245747-08-4 |
分子式 | C17H9F7N4O |
分子量 | 418.27 |
SMILES Code | O=C(C1=C(F)C=NC=C1)NC2=CC=C(N3N=C(C(F)(F)F)C=C3C(F)(F)F)C=C2 |
MDL No. | MFCD28385867 |
别名 | N-[4-[3,5-Bis(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-3-fluoro-4-pyridinecarboxamide |
运输 | 蓝冰 |
InChI Key | XZIQSOZOLJJMFN-UHFFFAOYSA-N |
Pubchem ID | 10598093 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Sealed in dry, 2-8°C |
溶解方案 |
请根据您的动物给药指南选择适当的溶解方案。 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|